IBT
ORIC icon

International Biotechnology Trust’s Oric Pharmaceuticals ORIC Stock Holding History

International Biotechnology Trust’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-176,217
Closed -$905K – 80
2022
Q1 		$905K Buy
176,217
+23,217
+15% +$209K 0.2% 56
2021
Q4 		$2.25M Buy
153,000
+100,000
+189% +$1.56M 0.5% 42
2021
Q3 		$1.1M Hold
53,000
– – 0.27% 53
2021
Q2 		$938K Hold
53,000
– – 0.25% 53
2021
Q1 		$1.3M Hold
53,000
– – 0.34% 44
2020
Q4 		$1.79M Buy
+53,000
New +$1.52M 0.49% 36

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

International Biotechnology Trust's ORIC Position: Q2 2022 in Review

International Biotechnology Trust sold out of Oric Pharmaceuticals (ORIC) in Q2 2022, closing a stake of 176,217 shares — an estimated $905K sold.

International Biotechnology Trust first reported a position in ORIC in Q4 2020 and held it in 6 quarters. The position peaked at $2.25M in Q4 2021. 83 funds tracked by Wall St. Rank hold ORIC as of Q2 2022.

  • International Biotechnology Trust reported no remaining Oric Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 176,217 Oric Pharmaceuticals shares in Q2 2022, an estimated $905K.
  • International Biotechnology Trust first reported a position in Oric Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • International Biotechnology Trust's Oric Pharmaceuticals position peaked at $2.25M in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2022.

Based on International Biotechnology Trust's 13F filing for Q2 2022, filed 16 Aug 2022.